You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 2, AUGUST 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Rectal Cortisol in the Therapy of Ulcerative Colitis

RAPHAEL D. SCHWARTZ, M.D.; MURRAY BRODOFF, M.D.; GEORGE L. COHN, M.D.; HOWARD M. SPIRO, M.D.

AMA Arch Intern Med. 1959;104(2):260-263.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The successful use of topical steroid therapy in diseases of the eye, skin, and joints has led to an evaluation of the effect of cortisol enemas in idiopathic ulcerative colitis. Observations from this laboratory have implied negligible absorption of cortisone from the rectum in ulcerative colitis. and so a relative absence of side-effects was to be anticipated.1 Truelove and others have reported encouraging results with rectal hydrocortisone in ulcerative colitis.2,3 This report represents an attempt to define the type of patient in whom such therapy might be most helpful.

Methods

All 16 patients studied had the diagnosis of ulcerative colitis confirmed by sigmoidoscopy and x-ray examination at either the Grace-New Haven Community Hospital or the West Haven Veterans Administration Hospital. Stool examinations were performed to exclude amebiasis, bacillary dysentery, and other causes of diarrhea; many patients had received antiamebic therapy on an empirical basis. Table 1 illustrates an . . . [Full Text PDF of this Article]


Author Affiliations

New Haven, Conn.

From the Department of Internal Medicine, Yale University School of Medicine.


Footnotes

Submitted for publication Dec. 4, 1958.

Supported in part by U. S. Public Health Grants C-2578 and A-1785.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.